Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 20 | 2025 | 1357 | 2.300 |
Why?
|
| Diabetes Mellitus, Type 1 | 14 | 2026 | 824 | 1.590 |
Why?
|
| Insulin Resistance | 6 | 2025 | 665 | 0.970 |
Why?
|
| Hypoglycemic Agents | 13 | 2025 | 456 | 0.950 |
Why?
|
| Lipoproteins | 1 | 2025 | 183 | 0.820 |
Why?
|
| Hypoglycemia | 5 | 2025 | 176 | 0.800 |
Why?
|
| Blood Glucose | 16 | 2025 | 1081 | 0.720 |
Why?
|
| Metformin | 4 | 2020 | 159 | 0.660 |
Why?
|
| Hyperglycemia | 4 | 2022 | 225 | 0.590 |
Why?
|
| Atherosclerosis | 1 | 2025 | 930 | 0.520 |
Why?
|
| Adolescent | 28 | 2026 | 20156 | 0.440 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 662 | 0.440 |
Why?
|
| Insulin | 7 | 2022 | 1128 | 0.420 |
Why?
|
| Transition to Adult Care | 2 | 2026 | 122 | 0.390 |
Why?
|
| Blood Glucose Self-Monitoring | 4 | 2025 | 127 | 0.360 |
Why?
|
| Self Care | 4 | 2026 | 228 | 0.340 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 631 | 0.270 |
Why?
|
| Social Support | 2 | 2026 | 369 | 0.250 |
Why?
|
| Depression | 5 | 2025 | 1296 | 0.230 |
Why?
|
| Automobile Driving | 1 | 2025 | 29 | 0.220 |
Why?
|
| Wearable Electronic Devices | 2 | 2025 | 114 | 0.220 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2025 | 72 | 0.220 |
Why?
|
| Affect | 1 | 2025 | 167 | 0.210 |
Why?
|
| Self-Management | 1 | 2026 | 111 | 0.210 |
Why?
|
| Humans | 37 | 2026 | 127501 | 0.210 |
Why?
|
| Peer Group | 1 | 2024 | 121 | 0.200 |
Why?
|
| Mentors | 1 | 2024 | 154 | 0.190 |
Why?
|
| Young Adult | 8 | 2026 | 9702 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2025 | 189 | 0.190 |
Why?
|
| Quality of Life | 3 | 2024 | 2032 | 0.190 |
Why?
|
| Medication Adherence | 3 | 2020 | 329 | 0.190 |
Why?
|
| Male | 23 | 2026 | 62895 | 0.180 |
Why?
|
| Female | 24 | 2026 | 68765 | 0.180 |
Why?
|
| Puberty | 1 | 2021 | 103 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1436 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 482 | 0.160 |
Why?
|
| Stress, Psychological | 1 | 2025 | 553 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 886 | 0.160 |
Why?
|
| Child | 18 | 2022 | 25302 | 0.160 |
Why?
|
| Vaccination | 1 | 2025 | 1003 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 116 | 0.150 |
Why?
|
| Age of Onset | 1 | 2020 | 611 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 143 | 0.140 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 16 | 0.140 |
Why?
|
| Medicaid | 1 | 2020 | 242 | 0.140 |
Why?
|
| Drug Monitoring | 1 | 2020 | 275 | 0.130 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 112 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2020 | 4987 | 0.120 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 305 | 0.120 |
Why?
|
| Adult | 9 | 2026 | 30603 | 0.120 |
Why?
|
| Glucagon | 1 | 2016 | 146 | 0.120 |
Why?
|
| Insulin Infusion Systems | 3 | 2022 | 64 | 0.120 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 61 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2025 | 1406 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 873 | 0.110 |
Why?
|
| Family | 2 | 2009 | 580 | 0.110 |
Why?
|
| Accelerometry | 2 | 2025 | 65 | 0.110 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2014 | 19 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 66 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 790 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 345 | 0.090 |
Why?
|
| Heart Atria | 1 | 2014 | 324 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2021 | 1659 | 0.080 |
Why?
|
| Biomarkers | 1 | 2020 | 3252 | 0.080 |
Why?
|
| Risk Factors | 5 | 2021 | 10636 | 0.080 |
Why?
|
| Cysteine | 1 | 2010 | 137 | 0.080 |
Why?
|
| Machine Learning | 2 | 2025 | 325 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 161 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2023 | 423 | 0.080 |
Why?
|
| Glutathione | 1 | 2010 | 195 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 760 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2025 | 968 | 0.070 |
Why?
|
| Glucose | 2 | 2023 | 839 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2011 | 464 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 198 | 0.070 |
Why?
|
| Obesity | 3 | 2015 | 2338 | 0.070 |
Why?
|
| Parents | 1 | 2015 | 1077 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2007 | 20 | 0.070 |
Why?
|
| United States | 2 | 2020 | 11425 | 0.070 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 2038 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2009 | 254 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 44 | 0.060 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 51 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 52 | 0.060 |
Why?
|
| Photoplethysmography | 1 | 2025 | 9 | 0.060 |
Why?
|
| Health Promotion | 1 | 2007 | 404 | 0.050 |
Why?
|
| Health Behavior | 1 | 2007 | 387 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Exercise | 1 | 2007 | 845 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2999 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 146 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1105 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2022 | 14467 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5161 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6247 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 235 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 49 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 80 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 686 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 252 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 409 | 0.030 |
Why?
|
| Androgens | 1 | 2018 | 269 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 477 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 129 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2015 | 4 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 2623 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 436 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 419 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1148 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 204 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 539 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 25 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2014 | 33 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 107 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 882 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2110 | 0.020 |
Why?
|
| Testosterone | 1 | 2018 | 597 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1601 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2125 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 2814 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2080 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 971 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17080 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 20 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4803 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2010 | 69 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 49 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 127 | 0.020 |
Why?
|
| Prednisone | 1 | 2009 | 241 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 190 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2010 | 205 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 1115 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 299 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2009 | 256 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6172 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1314 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 42 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 169 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 12583 | 0.020 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 220 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 79 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 440 | 0.020 |
Why?
|
| Texas | 2 | 2007 | 3564 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2009 | 337 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 27886 | 0.020 |
Why?
|
| Community Health Services | 1 | 2007 | 89 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 92 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 62 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2007 | 68 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1336 | 0.020 |
Why?
|
| Magnesium | 1 | 2006 | 119 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 57 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 248 | 0.020 |
Why?
|
| Health Education | 1 | 2007 | 225 | 0.010 |
Why?
|
| Urban Population | 1 | 2007 | 276 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2007 | 439 | 0.010 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 393 | 0.010 |
Why?
|
| Minority Groups | 1 | 2007 | 256 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 755 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2006 | 300 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 962 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2003 | 49 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 655 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 20512 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2010 | 862 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 1239 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 180 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1031 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2006 | 829 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1759 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3076 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1868 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 3937 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 7426 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8372 | 0.010 |
Why?
|